Founded in 2014 in Miami, Florida, HeartIn Inc. is constantly driving innovations forward, aiming to accelerate the development of telemedicine and remote cardiology in particular. After more than 9 years since the initiation of the idea, dozens of various prototypes and continuous development, HeartIn is ready to present its product â the future of remote cardiac assessment, which is available already today. According to WHO, more than 10 000 000 people die every year due to cardiovascular diseases. What is even more shocking, 80% of these deaths could have been prevented. We live in a busy world, and itâs often hard to convince yourself to visit a hospital without actual need. Our goal is to provide people with an easy-to-use tool for medical grade accuracy heart monitoring, which can be performed anywhere. Source
No articles found.
Tocagen is a clinical-stage, cancer-selective gene therapy company developing firs...
Tocagen is a clinical-stage, cancer-selective g...
Avenue Therapeutics, Inc., a Fortress Biotech (NASDAQ: FBIO) Company, is a special...
Avenue Therapeutics, Inc., a Fortress Biotech (...
Allogene Therapeutics is a clinical stage biotechnology company pioneering the dev...
Allogene Therapeutics is a clinical stage biote...
For more than 40 years, IntriCon has been meeting the rising demand for smaller, p...
For more than 40 years, IntriCon has been meeti...
We are dedicated to the discovery, development, and commercialization of novel hig...
We are dedicated to the discovery, development,...
Iovance Biotherapeutics (formerly traded as Lion Biotechnologies) is focused on th...
Iovance Biotherapeutics (formerly traded as Lio...
BioTelemetry, Inc. is the leading remote medical technology company focused on the...
BioTelemetry, Inc. is the leading remote medica...
Join the National Investor Network and get the latest information with your interests in mind.